STEDIVAZE
Dead / Abandoned — Abandoned — no statement of use filed (as of 12 Nov 2018)
What this means for you
This application is over — abandoned 12 Nov 2018. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86571540
- Mark type
- Stylized text
- Filed
- 20 Mar 2015
- Published for opposition
- 11 Aug 2015
- Abandoned
- 12 Nov 2018
- Attorney of record
- David Vance
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, coronary vasodilating agents
Owner
- Adenosine Therapeutics, LLC, Charlottesville, VA, US
- Adenosine Therapeutics, LLC, Charlottesville, VA, US
Prosecution history
- 13 Nov 2018 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 12 Nov 2018 — ABANDONMENT - NO USE STATEMENT FILED
- 04 Jul 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Jul 2018 — SOU EXTENSION 5 GRANTED
- 06 Apr 2018 — SOU EXTENSION 5 FILED
- 28 Jun 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 May 2018 — NOTICE OF REVIVAL - E-MAILED
- 16 May 2018 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 16 May 2018 — PETITION TO REVIVE-GRANTED
- 16 May 2018 — TEAS PETITION TO REVIVE RECEIVED
- 07 May 2018 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 07 May 2018 — ABANDONMENT - NO USE STATEMENT FILED
- 10 Oct 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Oct 2017 — SOU EXTENSION 4 GRANTED
- 06 Oct 2017 — SOU EXTENSION 4 FILED